Acura Pharmaceuticals, Inc.
ACUR
$0.0066
$0.000915.79%
09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
---|---|---|---|---|---|
Net Income | -1.15M | -1.57M | -872.00K | -1.21M | -810.00K |
Total Depreciation and Amortization | 82.00K | 75.00K | 77.00K | 125.00K | 173.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
Total Other Non-Cash Items | -170.00K | -176.00K | -196.00K | 481.00K | 716.00K |
Change in Net Operating Assets | 843.00K | 536.00K | -388.00K | -117.00K | -196.00K |
Cash from Operations | -396.00K | -1.13M | -1.38M | -719.00K | -117.00K |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | 266.00K | 266.00K | 535.00K | 269.00K | -6.00K |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
Repurchase of Common Stock | -8.00K | -8.00K | -8.00K | -2.00K | -2.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -269.00K | -- | -- | -- | -- |
Cash from Financing | -8.00K | 261.00K | 530.00K | 270.00K | -5.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -404.00K | -871.00K | -849.00K | -449.00K | -122.00K |